Host-pathogen interactions : from bench to bedside meeting 2016

›8:45 (1h15)

Therapeutic strategies
Cyrille GRANDJEAN

›8:45 (50min)

Bacteriophage Therapy: From Proofs of Concept to Clinical Trials.
Laurent DEBARBIEUX

›9:35 (25min)

Immunotherapy With Anti-Programmed Death Cell 1 Receptor (PD-1) Antibody Improves Survival During Spinal Cord Injury After Staphylococcus aureus Pneumonia
Karim ASEHNOUNE

›10:00 (30min)

Break & Poster and Stand viewing

›10:30 (1h15)

Therapeutic strategies
Cyrille GRANDJEAN

›10:30 (50min)

Novel Antibacterial Approaches
Alexis DENIS

›11:20 (25min)

Antibacterial Activity of Some Butyrolactone Analogues on Streptococcus gordonii
Alaa SWEIDAN

›11:45 (2h)

Lunch & Poster and Stand Viewing

›13:45 (05min)

Award

›13:50 (2h05)

Innate Immunity
Karim ASEHNOUNE

›13:50 (50min)

The Misseducation of Antigen Presenting Cells Following Severe Infections
José VILLADANGOS

›14:40 (50min)

Disease Tolerance as a Defense Strategy Against Infection
Miguel SOARES

›15:30 (25min)

Specific Host and Candida Interactions Lead to Controlled or Persistent Infection Outcomes
Nidia ALVAREZ-RUEDA

›15:55 (20min)

Coffee break

›16:15 (50min)

Innate Immunity
Karim ASEHNOUNE

›16:15 (50min)

Candida albicans-Host Interaction: Insights from Proteomics.
Concha GIL

›17:05 (10min)

Conclusion